Disseminated histoplasmosis in patients with AIDS in Panama: A review of 104 cases

Clinical Infectious Diseases

Volumn 40, Issue 8, 2005, Pages 1199-1202

  Gutierrez, Maria Eugenia ^a,b   Canton, Alfredo ^a   Sosa, Nestor ^a   Puga, Esther ^a   Talavera, Leyda ^a  

^a Arnulfo Arias Madrid Hospital   (Panama)

^b NONE   (Panama)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD CULTURE; BONE MARROW BIOPSY; BONE MARROW CULTURE; CLINICAL FEATURE; DIARRHEA; FEVER; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HYPOKALEMIA; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PANAMA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTIFUNGAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HISTOPLASMOSIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANAMA;

EID: 16844384704     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/428842     Document Type: Review

References (24)

1. Deepe GS. Histoplasma capsulatum. In: Mandell G, Dolin R, Bennet J, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:2718-32.
2. Diercks FH, Kelly HB, Klite PD, Fuentes JJ, Miranda EA. Prevalence of histoplasmin reactivity among school children in Panama City, Republic of Panama, 1962-63. Arch Med Panamẽnos 1965; 14:53-9.
3. Filos-Diaz JA. Histoplasmosis in Panama: historical review and update. Rev Med Panama 1984; 9:8-21.
4. Martin M. Cutaneous reactivity of the Panamanian population against 3 fungal antigens. Rev Med Panama 1985; 10:60-5.
5. Joint United Nations Programme on HIV/AIDS, World Health Organization. Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections, 2004 update. Available at: http://www.unaids.org. Accessed 17 September 2004.
6. Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis Clin North Am 2003; 17:1-19.
7. Burke DG, Emancipator SN, Smith MC, Salata R. Histoplasmosis and kidney disease in patients with AIDS. Clin Infect Dis 1997; 25:281-4.
8. Wheat LJ. Histoplasmosis: experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 1997; 76:339-54.
9. Hajjeh RA. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(Suppl 1):S108-10.
10. Wheat J, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh R. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30:877-81.
11. Hajjeh RA, Pappas PG, Henderson H, et al. Multicenter case control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 2001; 32:1215-20.
12. McKinsey DS, Spiegel RA, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997; 24:1195-203.
13. Couppie P, Sobesky M, Aznar C, et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 2004; 38:134-8.
14. Butt AA, Michaels S, Greer D, Clark R, Kissinger P, Martin DH. Serum LDH level as a clue to the diagnosis of histoplasmosis. AIDS Read 2000; 12:317-21.
15. Johnson PC, Wheat J, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137:105-9.
16. Suh KN, Anekthananon T, Mariuz PR. Gastrointestinal histoplasmosis in patients with AIDS: case report and review. Clin Infect Dis 2001; 32:483-91.
17. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 2004; 38:1485-9.
18. Department of Epidemiological Surveillance, Public Health General Division, Ministry of Health. Cumulative report on AIDS situation: 1984-2004. Panama: Ministry of Health, 2004.
19. Pietrobon D, Negro-Marquinez L, Kilstein J, Galíndez J, Greca A, Battagliotti C. Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment [in Spanish]. Enferm Infecc Microbiol Clin 2004; 22:156-9.
20. Torales M, Cardozo A, Savio E. Disseminated histoplasmosis in HIV positive patients: seven years of experience [in Spanish]. In: Program and abstracts of the XIth Panamerican Congress of Infectious Diseases (Cordoba, Argentina), 2003. Available at: http://www.clinfec.org. Accessed 28 August 2004.
21. Corti ME, Negroni R, Esquivel P, Villafañe MF. Disseminated histoplasmosis in patients with AIDS: epidemiological, clinical, microbiological and immunological analysis of 26 patients [in Spanish]. Enferm Emerg 2004; 6:8-15.
22. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361-74.
23. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
24. Ledergerber B, Egger M, Erard V, et al. AIDS related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999; 282:2220-6.